Marksans Pharma consolidated net profit rises 34.64% in the September 2022 quarter

15 Nov 2022 , 08:45 AM

Net profit of Marksans Pharma rose 34.64% to Rs 61.25 crore in the quarter ended September 2022 as against Rs 45.49 crore during the previous quarter ended September 2021. Sales rose 25.30% to Rs 452.57 crore in the quarter ended September 2022 as against Rs 361.20 crore during the previous quarter ended September 2021.

Particulars	Quarter Ended
?	Sep. 2022	Sep. 2021	% Var.
Sales	452.57	361.20	25
OPM %	17.74	16.64	–
PBDT	91.88	67.16	37
PBT	77.83	59.78	30
NP	61.25	45.49	35

Powered by Capital Market – Live News